- Home
- PMTS vs NLSP Comparison
PMTS vs NLSP Comparison
Compare PMTS & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- NLSP
- Stock Information
- Founded
- PMTS 2007
- NLSP 2015
- Country
- PMTS United States
- NLSP Switzerland
- Employees
- PMTS N/A
- NLSP N/A
- Industry
- PMTS Finance Companies
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- PMTS Finance
- NLSP Health Care
- Exchange
- PMTS Nasdaq
- NLSP Nasdaq
- Market Cap
- PMTS 259.2M
- NLSP 243.8M
- IPO Year
- PMTS 2015
- NLSP 2021
- Fundamental
- Price
- PMTS $26.88
- NLSP $3.13
- Analyst Decision
- PMTS Strong Buy
- NLSP
- Analyst Count
- PMTS 3
- NLSP 0
- Target Price
- PMTS $32.00
- NLSP N/A
- AVG Volume (30 Days)
- PMTS 33.5K
- NLSP 624.8K
- Earning Date
- PMTS 11-05-2024
- NLSP 11-22-2024
- Dividend Yield
- PMTS N/A
- NLSP N/A
- EPS Growth
- PMTS N/A
- NLSP N/A
- EPS
- PMTS 1.30
- NLSP N/A
- Revenue
- PMTS $458,377,000.00
- NLSP N/A
- Revenue This Year
- PMTS $9.16
- NLSP N/A
- Revenue Next Year
- PMTS $7.71
- NLSP N/A
- P/E Ratio
- PMTS $20.63
- NLSP N/A
- Revenue Growth
- PMTS N/A
- NLSP N/A
- 52 Week Low
- PMTS $15.00
- NLSP $3.00
- 52 Week High
- PMTS $31.00
- NLSP $29.08
- Technical
- Relative Strength Index (RSI)
- PMTS 60.16
- NLSP 30.46
- Support Level
- PMTS $26.01
- NLSP $3.56
- Resistance Level
- PMTS $28.30
- NLSP $4.15
- Average True Range (ATR)
- PMTS 1.09
- NLSP 0.46
- MACD
- PMTS 0.43
- NLSP -0.05
- Stochastic Oscillator
- PMTS 79.12
- NLSP 7.47
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.